Skip to main content
CRBU
NASDAQ Life Sciences

Caribou Biosciences Narrows Q1 Loss, $118.6M Cash Extends Runway, Reports Positive Clinical Data

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.87
Mkt Cap
$182.268M
52W Low
$0.73
52W High
$3.535
52W Position info
156% above low
Off High info
47% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

CRBU has more than doubled off its 52-week low of $0.73.

Summary

Caribou Biosciences reported first-quarter 2026 results with revenue of $2.4M and a net loss of ($25.09M), or ($0.26) per share, representing a significant narrowing of the net loss year-over-year. Crucially, the company reported $118.6M in cash and securities, which management expects to fund operations for at least 12 months. This is a material positive development, especially considering the previous 10-K (March 5, 2026) had indicated insufficient funds for a planned pivotal clinical trial. Additionally, the company announced positive clinical milestones, including an 86% overall response rate for its ANTLER phase 1 optimized cohort for Vispa-cel and a 92% ORR for CB-011 in BCMA-naive patients. Traders will monitor the company's progress in securing additional financing and further clinical trial results.

At the time of this announcement, CRBU was trading at $1.87 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $182.3M. The 52-week trading range was $0.73 to $3.54. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CRBU - Latest Insights

CRBU
Oct 06, 2026, 4:37 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.705
Real-time Price: $0.432 info
Change: -$0.273 (-39%) info
Market Cap: $47.643M info
CRBU
Oct 06, 2026, 4:11 PM EDT
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.432 info
Change: -$0.703 (-62%) info
Market Cap: $47.643M info
CRBU
Oct 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.432 info
Change: -$0.703 (-62%) info
Market Cap: $47.643M info
CRBU
Aug 13, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $0.432 info
Change: -$1.18 (-73%) info
Market Cap: $47.643M info
CRBU
Aug 13, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.62
Real-time Price: $0.432 info
Change: -$1.19 (-73%) info
Market Cap: $47.643M info